Show simple item record

Connective tissue activation

dc.contributor.authorCabral, Antonio R.en_US
dc.contributor.authorCastor, C. Williamen_US
dc.date.accessioned2006-04-28T16:23:14Z
dc.date.available2006-04-28T16:23:14Z
dc.date.issued1983-11en_US
dc.identifier.citationCabral, A.; Castor, C. W. (1983)."Connective tissue activation." Arthritis & Rheumatism 26(11): 1362-1369. <http://hdl.handle.net/2027.42/37761>en_US
dc.identifier.issn0004-3591en_US
dc.identifier.issn1529-0131en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/37761
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6639695&dopt=citationen_US
dc.description.abstractFour normal (NF) and 4 scleroderma skin fibro-blast (SF) strains were compared with respect to 1) basal 14 C-glucosamine and 35 SO 4 -labeled glycosaminoglycan (GAG) synthesis, 2) responsiveness to autacoid mediators, and 3) performance following maximal stimulation. Under basal conditions, SF synthesized and secreted 2–3 times more radioactive hyaluronic acid than the NF ( P < 0.001); molecular volume by gel chromatography was similar and suggested a high molecular weight product. SF were essentially as responsive to normal lymphoid and platelet factors as were NF. No consistent qualitative or quantitative differences in sulfated GAG synthesis were noted between the 2 groups of cells. Incubation of NF and SF with a false “core protein” such as p-nitrophenyl-Β-D-xyloside suggested that synthesis of the core protein was rate limiting; SF and NF were equally facile in SO 4 -GAG chain synthesis in the presence of a Β-xyloside. SF appear to retain in vitro a partially activated state for many generations, at least with respect to hyaluronic acid synthesis.en_US
dc.format.extent709605 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherJohn Wiley & Sons, Inc.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherRheumatologyen_US
dc.titleConnective tissue activationen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumRackham Arthritis Research Unit, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor.en_US
dc.contributor.affiliationumRackham Arthritis Research Unit, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor. ; Rackham Arthritis Research Unit, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109en_US
dc.identifier.pmid6639695en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/37761/1/1780261109_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/art.1780261109en_US
dc.identifier.sourceArthritis & Rheumatismen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.